Tag: Unfair Methods of Competition

Displaying 1 - 20 of 21 results.

In testimony presented to a U.S. House of Representatives Judiciary subcommittee the Federal Trade Commission described its ongoing efforts to protect competition and consumers in many important sectors of the economy, including health care, pharmaceuticals, and technology.
Google Inc. has agreed to change some of its business practices to resolve Federal Trade Commission concerns that those practices could stifle competition in the markets for popular devices such as smart phones, tablets and gaming consoles, as well as the market for online search advertising.
On 11/26/2012, the FTC required Robert Bosch GmbH to sell a business that makes equipment used to recharge vehicle air conditioning systems as part of an agreement resolving charges that Bosch’s acquisition of SPX Service Solutions U.S. LLC would have been anticompetitive. Under the...
Two consent orders announced by the Federal Trade Commission today both resolve the competitive concerns about Chevron Corporation’s (Chevron) proposed $18 billion acquisition of Unocal Corporation (Unocal), and settle the Commission’s 2003 monopolization complaint against Unocal alleging...
The Federal Trade Commission today reinstated charges that the Union Oil Company of California violated antitrust laws by defrauding the California Air Resources Board (CARB) in connection with regulatory proceedings regarding development of reformulated gasoline.
Chief Administrative Law Judge Stephen J. McGuire today issued his initial decision and order in the matter of Rambus, Inc. The order states "Accordingly, Complaint Counsel having failed to sustain its burden of establishing liability for the violations alleged, the Complaint is Dismissed." That...
The Federal Trade Commission today issued an administrative complaint against Union Oil Company of California (Unocal) for allegedly committing fraud in connection with regulatory proceedings before the California Air Resources Board (CARB) regarding the development of reformulated gasoline (RFG).
Mylan Laboratories, Inc., the nation’s second largest generic drug manufacturer, and three other companies, were charged today by the Federal Trade Commission with restraint of trade, monopolization and conspiracy to monopolize the markets for two widely-prescribed anti-anxiety drugs, lorazepam...

Pages